Citation tools
"Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis." The Journal of Rheumatology
(2019):
jrheum.171469.
Web. 28 Mar. 2024.